Custom Lucite, with an embedded drug vial, celebrating FDA approval of Cosela. (20ADH005)
Custom Lucite, with an embedded drug vial, celebrating FDA approval of Cosela. (20ADH005)
Custom Lucite with an embedded drug vial commemorating FDA approval of ELAHERE. Developed by ImmunoGen, the drug was granted accelerated FDA approval as a treatment for ovarian cancer. (23AKL266)
Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, the drug is intended for the treatment of obstructive sleep apnea. (23AZH173)
Custom Award recognizing contributions to the development of a medical implant, and embedding the actual device within Lucite. (23AZH106)
Crystal tombstone celebrating a favorable verdict in an antitrust action against Gilead Sciences. The claim had centered on an earlier patent settlement involving Gilead and Teva. (23AKL380)
Crystal commemorative celebrating FDA approval of Ogsiveo, a treatment for desmoid tumors. (24aZH051)
Launch recognition product commemorating a the first in human study by Catabasis Pharmaceuticals, based in Cambridge, MA
Custom deal toy commemorating the initial public offering of Spring Bank Pharmaceuticals, a clinical-stage biopharmaceutical company based in Hopkinton, Massachusetts. The firm has focused on small-molecule therapies for hepatitis B and viral diseases.
(6AKLA83)
